Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Article focus Intravenous (IV) tranexamic acid is routinely used in hip and knee arthroplasty. The optimum dose and route of administration is still debated. We have increased the dose used in our enhanced recovery (ER) protocol from 15 mg/kg to 30 mg/kg (maximum 2.5 g) as a single, IV dose. We report the clinical effect of this dosage change. Key messages The higher dose of 30 mg/kg (maximum 2.5 g) as a single IV dose reduced transfusion requirements.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
